Derek L Chappell

533 total citations
15 papers, 329 citations indexed

About

Derek L Chappell is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Spectroscopy. According to data from OpenAlex, Derek L Chappell has authored 15 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Spectroscopy. Recurrent topics in Derek L Chappell's work include Advanced Proteomics Techniques and Applications (4 papers), Mass Spectrometry Techniques and Applications (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Derek L Chappell is often cited by papers focused on Advanced Proteomics Techniques and Applications (4 papers), Mass Spectrometry Techniques and Applications (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Derek L Chappell collaborates with scholars based in United States, United Kingdom and South Africa. Derek L Chappell's co-authors include Omar Laterza, Michael E. Lassman, Thomas McAvoy, Scott J. Cameron, Haihong Zhou, Gary B. Green, Lori J. Sokoll, Aimée Dallob, Karen Snyder and José Castro‐Perez and has published in prestigious journals such as Clinical Chemistry, Clinical Pharmacology & Therapeutics and Clinica Chimica Acta.

In The Last Decade

Derek L Chappell

15 papers receiving 322 citations

Peers

Derek L Chappell
Katsuji Hattori Japan
Christelle Perros-Huguet United Kingdom
Nansie A. McHugh United States
Masashi Ukai Japan
Naoto Terada Japan
Maria Cristina De Vera Mudry Switzerland
J. Schloos Germany
H. Wick Switzerland
B. Brooks Israel
L. Mike Furness United States
Katsuji Hattori Japan
Derek L Chappell
Citations per year, relative to Derek L Chappell Derek L Chappell (= 1×) peers Katsuji Hattori

Countries citing papers authored by Derek L Chappell

Since Specialization
Citations

This map shows the geographic impact of Derek L Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek L Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek L Chappell more than expected).

Fields of papers citing papers by Derek L Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek L Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek L Chappell. The network helps show where Derek L Chappell may publish in the future.

Co-authorship network of co-authors of Derek L Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Derek L Chappell. A scholar is included among the top collaborators of Derek L Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek L Chappell. Derek L Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lassman, Michael E., Derek L Chappell, Thomas McAvoy, et al.. (2020). Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans. Clinical Pharmacology & Therapeutics. 109(6). 1575–1582. 3 indexed citations
2.
Lassman, Michael E., et al.. (2016). The clinical utility of mass spectrometry based protein assays. Clinica Chimica Acta. 459. 155–161. 10 indexed citations
3.
Li, Xiaofang, Elizabeth J. Parks, David G. McLaren, et al.. (2016). An LC-Mrm Method for Measuring Intestinal Triglyceride Assembly Using an Oral Stable Isotope-Labeled Fat Challenge. Bioanalysis. 8(12). 1265–1277. 3 indexed citations
4.
Chappell, Derek L, et al.. (2016). Development and Validation of an IA-LC/MS Method to Quantitate Active and Total B-Type Natriuretic Peptide in Human Plasma. Bioanalysis. 8(22). 2341–2349. 10 indexed citations
5.
Lassman, Michael E., et al.. (2016). An Evaluation of an Aptamer for Use as an Affinity Reagent with MS: PCSK9 as an Example Protein. Bioanalysis. 8(15). 1557–1564. 17 indexed citations
6.
Lee, Anita Y. H., Derek L Chappell, Monika Bąk, et al.. (2015). Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test. Clinical Chemistry. 62(1). 227–235. 39 indexed citations
7.
Seeburger, Jeffrey L., Daniel Holder, Marc Combrinck, et al.. (2015). Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort. Journal of Alzheimer s Disease. 44(2). 525–539. 62 indexed citations
8.
Lassman, Michael E., Thomas McAvoy, Anita Y. H. Lee, et al.. (2014). Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins. Clinical Chemistry. 60(9). 1217–1224. 29 indexed citations
9.
Chappell, Derek L, Michael E. Lassman, Thomas McAvoy, et al.. (2014). Quantitation of Human Peptides and Proteins Via MS: Review of Analytically Validated Assays. Bioanalysis. 6(13). 1843–1857. 26 indexed citations
10.
Chappell, Derek L, José Castro‐Perez, Haihong Zhou, et al.. (2013). An Ultrasensitive Method for The Quantitation of Active and Inactive Glp-1 in Human Plasma Via Immunoaffinity LC–MS/MS. Bioanalysis. 6(1). 33–42. 29 indexed citations
11.
Chappell, Derek L, et al.. (2012). Development And Validation of An Ultra-Sensitive Method For The Measurement of Plasma Renin Activity in Human Plasma Via Lc–MS/MS. Bioanalysis. 4(23). 2843–2850. 20 indexed citations
12.
Chappell, Derek L, et al.. (2011). Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI2). Journal of Pharmaceutical and Biomedical Analysis. 56(3). 600–603. 7 indexed citations
13.
Schwartz, Jules I., Aimée Dallob, Patrick Larson, et al.. (2008). Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects. The Journal of Clinical Pharmacology. 48(6). 745–754. 35 indexed citations
14.
15.
Laterza, Omar, Scott J. Cameron, Derek L Chappell, Lori J. Sokoll, & Gary B. Green. (2004). Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clinica Chimica Acta. 348(1-2). 163–169. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuji Hattori Breakdown of academic impact, for papers by Christelle Perros-Huguet Breakdown of academic impact, for papers by Nansie A. McHugh Breakdown of academic impact, for papers by Masashi Ukai Breakdown of academic impact, for papers by Naoto Terada Breakdown of academic impact, for papers by Maria Cristina De Vera Mudry Breakdown of academic impact, for papers by J. Schloos Breakdown of academic impact, for papers by H. Wick Breakdown of academic impact, for papers by B. Brooks Breakdown of academic impact, for papers by L. Mike Furness
Rankless by CCL
2026